Lastly, the systemic effects of GLP-1RAs, such as body weight loss [103] and potential reduction in muscle mass [104], pose significant challenges for elderly individuals with neurodegenerative diseases
The timing is favorable
Anyone who feels faint while taking a drug like semaglutide should notify the prescriber
Semaglutide and other GLP-1 drugs effectively control blood sugar levels , a key component of managing type 2 diabetes
(Dakota News Now) - In South Dakota specifically, obesity affects 36% of people, and 46.1% of those are non-Hispanic, American-Indian, or Alaska native adults, according to the CDC
These results align with the growing body of evidence suggesting that GLP-1 receptor agonists hold promise for mitigating CV outcomes in patients with T2D